Trials / Unknown
UnknownNCT04508712
Long-term Outcomes in Patients With COVID-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 900 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Long-term outcomes from coronavirus disease 2019 (COVID-19) are currently unknown. This study will collect daily living status of survivors of COVID-19.
Detailed description
The ongoing pandemic of coronavirus disease 2019 (COVID-19), due to the newly discovered severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2), has caused a worldwide increase in hospitalization for pneumonia with multi- organ disease. Survival from sepsis is associated with increased risk for mortality for at least 2 years. Therefore, substantial sequelae including new physical disability, new cognitive impairment and increased vulnerability to further health deterioration are likely to be seen in survivors of COVID-19. The investigators conduct this study to investigate daily living status of survivors of COVID-19 using telephone interview questionnaire including Activity Daily Living(ADL), modified Medical Research Council(mMRC),modified Telephone Interview for Cognitive Status (TICS-m), Zung Self-rating Depression Scale(SDS), Carcinologic Handicap Index (CHI), and New York Heart Association (NYHA) functional class.
Conditions
Timeline
- Start date
- 2020-08-10
- Primary completion
- 2021-08-31
- Completion
- 2021-08-31
- First posted
- 2020-08-11
- Last updated
- 2020-10-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04508712. Inclusion in this directory is not an endorsement.